Diabetes Risk And Moderate Drinking

Diabetes Risk and Moderate Drinking

Diabetes Risk and Moderate Drinking

Researchers also looked at what people were drinking.
Men and women who had seven or more glasses of wine per week had a 25-30 percent lower risk of diabetes, compared with people who had less than one drink per week, according to a press release .
This fits with an earlier meta-analysis of 13 studies that found that moderate wine drinkers had a 20 percent lower risk of diabetes, compared with abstainers or light drinkers.
The researchers suggest that natural phytochemical compounds found in red wine may have beneficial effects on blood sugar levels.
Men who drank between one and six beers each week had a 21 percent lower risk of diabetes, compared with men who drank less than one beer each week. Researchers found no link between beer drinking and diabetes risk in women.
In women, drinking seven or more drinks of liquor each week increased their risk of diabetes by 83 percent, compared with women who drank less than one each week. There was no link between mens liquor consumption and their diabetes risk.
A relatively small number of people in the study, though, reported heavy consumption of spirits.
Dr. William Cefalu, chief scientific, medical, and mission officer for the American Diabetes Association, cautioned that given the observational nature of the data, its difficult to draw firm conclusions about any real difference between men and women in the effect of spirit consumption.
Cefalu told Healthline that one of the strengths of the study was the large number of people surveyed.
But he said the study had certain limitations, including a small number of peopl Continue reading

Rate this article
Total 1 ratings
Closed-Loop Insulin Pump Brightens Future of Diabetes Management

Closed-Loop Insulin Pump Brightens Future of Diabetes Management

Closed-Loop Insulin Pump Brightens Future of Diabetes Management
This story is part ofMD Magazine's Year-End Recap series.
Click here for Part 1 , a look into the success of ketamine as a multifaceted therapy.
Click here for Part 2 , a look at the future of Alzheimer's Disease therapies.
For patients with type 1 diabetes (T1D), one of the biggest burdens of the condition is the need to manage it - more specifically, to manage their blood glucose levels .
With the September 2016 approval of the MiniMed670GInsulin Pump System by the US Food and Drug Administration (FDA), produced by Medtronic, the patients ability to manage their glucose became much easier.
Normally, patients with T1D need to monitor their continuous glucose monitoring sensor and use the information the sensor provides them to predict and adjust the dose of insulin they set their pump toadminister. While that open loop system is a major improvement from the previously used multiple daily injections, it still puts a burden on the patient, especially at night and for pediatric patients.
Medtronics device, however, is the first of its kind featuring a closed loop system that self-adjusts to the individual wearer. This allows for real-time alterations in insulin based on the needs at the time, and it is currently the only such device on the market that is able to control dosing automatically. Now, the system does the work for the patient.
Our previous approach with the old pump systems, with set basal rates of insulin infusion that change every couple hours at most, was very nave and inadequate, Kevin P Continue reading

Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Effects of Insulin Plus Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in Treating Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Combination therapy with insulin and glucagon-like peptide-1 receptor agonists (GLP-1RAs) has already been proven an efficient treatment option for type 2 diabetes. This combination can effectively improve glycated hemoglobin levels, cause weight loss and reduce the dosage of insulin. In addition, it can also reduce the risk of hypoglycemia. Several randomized controlled trials have confirmed that this treatment may be just as effective for type 1 diabetes mellitus (T1DM) patients. The objective of this meta-analysis was to assess the effects and efficacy of the treatment on glycemic changes, weight loss and insulin dosage in type 1 diabetes mellitus patients.
We searched Embase, PubMed and Cochrane for randomized controlled trials (no time restrictions) that investigated combined insulin and GLP-1 treatment. The main endpoints were measurements of glycated hemoglobin and changes in the weight and the dosage of insulin.
In total, 1093 were studies identified, and 7 studies were included in our meta-analysis. GLP-1 agonist and insulin combination therapy led to greater reductions in HbA1c levels [P = 0.03; mean difference −0.21; 95% confidence intervals (CI) (−0.40, 0.02)] and weight [P < 0.05; −3.53 (−4.86, 2.19)] compared to control treatments. The combination therapy did not significantly influence the daily weight-adjusted total insulin dose [P = 0.05; −0.11 (−0.23, 0)], but it did reduce the daily weight-adjusted bolus insulin dose [P = 0.001; −0.06 (−0.1, 0.02)].
Our meta-analysis supports the use of a combined therapeutic regimen of insulin an Continue reading

The use of animal models in diabetes research

The use of animal models in diabetes research

The use of animal models in diabetes research
Diabetes Research Group, King's College London, London, UK
Aileen King, Diabetes Research Group, Guy's Campus, King's College London, London SE1 1UL, UK. E-mail: [email protected]
Received 2011 Aug 19; Revised 2012 Feb 10; Accepted 2012 Feb 13.
Copyright 2012 The Author. British Journal of Pharmacology 2012 The British Pharmacological Society
This article has been cited by other articles in PMC.
Diabetes is a disease characterized by a relative or absolute lack of insulin, leading to hyperglycaemia. There are two main types of diabetes: type 1 diabetes and type 2 diabetes. Type 1 diabetes is due to an autoimmune destruction of the insulin-producing pancreatic beta cells, and type 2 diabetes is caused by insulin resistance coupled by a failure of the beta cell to compensate. Animal models for type 1 diabetes range from animals with spontaneously developing autoimmune diabetes to chemical ablation of the pancreatic beta cells. Type 2 diabetes is modelled in both obese and non-obese animal models with varying degrees of insulin resistance and beta cell failure. This review outlines some of the models currently used in diabetes research. In addition, the use of transgenic and knock-out mouse models is discussed. Ideally, more than one animal model should be used to represent the diversity seen in human diabetic patients.
This paper is the latest in a series of publications on the use of animal models in pharmacology research. Readers might be interested in the previous papers.
Robinson V (2009). Less is more: reducin Continue reading

Most People with Diabetes Should Stop Iron Supplements

Most People with Diabetes Should Stop Iron Supplements

February 16, 2017 by David Mendosa
When you have too much iron in your blood or stored elsewhere in your body might be why your blood glucose level is above normal. In fact, too much iron can even be why you got diabetes. Yet about one out of every five Americans regularly takes an iron supplement.
For years researchers have suspected that when your body accumulates too much iron you are at risk of a host of diseases, according to Berkeley Wellness . In addition to diabetes, iron overload is linked to colorectal cancer, high blood pressure, and hardening of the arteries, as well as to strokes, Alzheimers Disease, and Parkinsons disease.
But only now do we have studies demonstrating the connection between excess iron and diabetes.
Even mildly elevated body iron contributes to the prevalence and incidence of type 2 diabetes, states the news release from the University of Eastern Finland announcing the publication of these studies.
One of these recent studies looked at why men are more likely to have diabetes than women. The International Diabetes Federation estimated that 215.2 million men and 199.5 million women a difference of more than 15 million people had diabetes worldwide in 2015.
Only the abstract of this study, Gender difference in type 2 diabetes and the role of body iron stores , is free online. But the lead author, Alex Aregbesola, M.D., Ph.D., emailed me the full text upon my request. Dr. Aregbesola is a researcher at the Institute of Public Health and Clinical Nutrition, University of Eastern Finland. This study, which includes a prospectiv Continue reading

No more pages to load

Popular Articles

  • Drinking red wine regularly reduces risk of diabetes

    Drinking red wine three to four times a week lowers the risk of developing type 2 diabetes according to a recent study by Danish researchers. The study, carried out on over 70,000 people over five years, was published in Diabetologia and monitored how much and how often they drank. The results found that drinking moderately three to four times a week reduced a woman’s risk of type 2 diabetes by ...

  • Eating fruit significantly cuts diabetes risk - but drinking juice INCREASES it, says study

    INDYPULSE Eating fruit significantly cuts diabetes risk - but drinking juice INCREASES it, says study Eating blueberries, grapes, apples and pears cuts the risk of type 2 diabetes but drinking fruit juice can increase it, a large study has found. Experts from the UK, Singapore and a team from Harvard School of Public Health in the US have examined whether certain fruits impact on type 2, which aff ...

  • Drinking a few times a week linked to lower diabetes risk

    Drinking three to four times a week has been linked to a lower risk of type 2 diabetes than never drinking, Danish researchers suggest. Wine appears to be particularly beneficial, probably as it plays a role in helping to manage blood sugar, the study, published in Diabetologia, says. They surveyed more than 70,000 people on their alcohol intake - how much and how often they drank. But experts sai ...

  • No, Drinking More Won't Lower Your Diabetes Risk

    You might have stumbled across some headlines recently declaring that drinking alcohol will lower your risk of type 2 diabetes. “Looking to Ward Off Diabetes? Drink Alcohol, Study Suggests,” proclaimed one article. “Regular Drinking Can Reduce Risk of Developing Diabetes,” another stated. If that seems a little off to you, you’re right. While research has found that moderate drinking is ...

  • How Can Drinking Wine Help Reduce Diabetes Risk?

    A new study suggests that frequent, moderate alcohol consumption might lower chance of developing Type 2 diabetes Researchers found that alcohol appeared to impact men and women differently when it comes to diabetes. Wine has been linked in multiple studies to a reduced risk of developing Type 2 diabetes and related health issues. Now, a group of researchers has found further evidence, suggesting ...

  • Are You at Risk for Type 2 Diabetes? Learn Common—and Not So Common—Risk Factors

    Diabetes is not a rare condition – in fact, it’s an epidemic in the U.S. More than 30 million Americans have type 2 diabetes and another 84 million have prediabetes, a condition of elevated blood sugar levels that often leads to type 2. Why do so many Americans have type 2 diabetes? Experts say this major public health problem is due to an aging population, increasing obesity rates and rising ...

  • Diabetes, Alcohol, and Social Drinking

    People with diabetes should be particularly cautious when it comes to drinking alcohol because alcohol can make some of the complications of diabetes worse. First of all, alcohol impacts the liver in doing its job of regulating blood sugar. Alcohol can also interact with some medications that are prescribed to people with diabetes. Even if you only rarely drink alcohol, talk with your healthcare p ...

  • Why Drinking Tea May Help Prevent and Manage Type 2 Diabetes

    The fountain of youth still remains elusive, but there's something that seems close: green tea. People have been drinking tea for centuries, and today it's the second most popular drink in the world (after water). Some of that popularity may stem from the many widely recognized benefits of tea, including its reported power to prevent cancer and to sharpen mental health. But tea may offer health be ...

  • Drinking with Diabetes: Dangers and Guidelines

    As we all know, diabetes involves following a careful diet plan, and that might mean having to cut back on some of your favorite indulgences. Wine and other alcoholic beverages are just a few of the treats that diabetics should enjoy sparingly – something that is often overlooked during a Q&A with the doctor. Dangers of Drinking Alcohol with Diabetes Because the body processes alcohol in the sam ...

Related Articles